WASHINGTON - Moderna Inc. said Tuesday its coronavirus vaccine has proven effective in adolescents between the ages of 12 and 17, raising the prospects of it becoming the second vaccine authorized for use on the age group in the United States.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
